• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    BMP Medical Expands Sterling, Massachusetts Facility

    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy

    Environmental Sustainability Becoming Increasingly Important to Medtech Industry

    Duane DiFranco Joins Harvard MedTech’s Medical Advisory Board

    Lionel Bonte Named President of Mativ’s Healthcare and Wellness Business Unit
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Halkey-Roberts Corporation

    Providence Enterprise USA Inc.

    JBC Technologies

    Medbio LLC

    LEMO USA Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Halkey-Roberts Corporation

    Providence Enterprise USA Inc.

    JBC Technologies

    Medbio LLC

    LEMO USA Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Catheter Ablation Technology and the Circular Economy

    How device manufacturers can benefit from this different methodology.

    Catheter Ablation Technology and the Circular Economy
    Based on current FDA clearances, fully leveraging single-use device reprocessing can save U.S. healthcare more than $700 million, reducing device spend from $2.5 billion to $1.8 billion.
    Related CONTENT
    • Heraeus Medevio
    • COVID Community: How the Pandemic Is Bringing Out the Best in Us
    • The FDA Wants to Bring Manufacturing ‘Home’
    • Innovation and Expertise Drive Evolution in Medical Device Manufacturing
    • Pandemic is Severely Impacting Reversible Contraceptive Devices Market
    Lars Thording, VP of Marketing & Public Affairs at Innovative Health LLC07.09.20
    Catheter ablation is one of the fastest growing service lines in U.S. healthcare. More and more patients are diagnosed with atrial fibrillation (AFib) and similar conditions, and electrophysiology (EP) labs are treating them as fast as they can diagnose them.
     
    Improvements in catheter ablation technology and methodology are not only having a great impact on patients and their quality of life, but are also making a mark financially: A new economic analysis estimates that $2.5 billion will be spent in 2020 on medical devices used for catheter ablation. At the level of the individual procedure, an AFib procedure absorbs about $10,500 in medical device costs alone. Commercial reimbursement for the procedure averages $33,417, while Centers for Medicare and Medicaid Services (CMS) reimburses catheter ablation as an outpatient procedure at about $20,700. This means catheter ablations are an important driver of profits where the payer mix is favorable – and that the financial sustainability of catheter ablation procedures is questionable where it is not.
     
    For device manufacturers, this delicate cost balance is going to become more important than ever going forward, as hospitals become less tolerant of higher costs for new technology, as well as the waste associated with single-use devices.
     
    When device costs are 50 percent of reimbursement, the financial equation is tough. And while CMS reimbursement has been going up in recent years, the constant and frequent roll-out of new catheter ablation technology is driving device costs up.
     
    This makes catheter ablation critically important from a financial perspective for many hospitals that offer EP procedures. This has become even more apparent after April and May, where hospitals experienced a mandatory shut-down of elective procedures. While catheter ablation procedures are among the procedures that usually present the hospital with a net profit, patient care and ICU units that take care of COVID-19 patients are less profitable. So, the shut-down stopped the profitable procedures and ramped up unprofitable activities. Modern Healthcare reported that hospital revenue fell 40-60 percent and YTD March operating income across U.S. hospitals was -8.1 percent. By May, this number was -18 percent.
     
    Lessons from the Pandemic
    To remain competitive in the future, device manufacturers need an appreciation of the challenges facing today’s hospitals. As hospitals take stock of their situations and evaluate how to manage costs, demand, and service line activities in a prolonged COVID-19 crisis, they need to look more fundamentally at technology utilization. Elective surgeries such as catheter ablation have opened up, although not yet at 100 percent. There are three important lessons to be learned from the COVID-19 pandemic:
     
    1. “Elective” procedures may threaten public health in a pandemic in the short term, but in the long term, elective procedures are necessary for the financial sustainability of the hospital – and therefore for public health. Hospitals need to find a way to continue elective procedures during a pandemic, by leaning out and better controlling the supply chain, and by finding an operational “fix” to a situation where very sick people as well as less sick people have to enter the hospital. Pent up demand for catheter ablations from the shut-down presents both a financial opportunity and a public health issue. This puzzle needs to be solved.
     
    2. Technology adoption needs to be managed from a combined patient care and financial perspective. The ultra-thin margins on which hospitals operate will no longer tolerate blind adoption of new technology just because it is “new technology,” or even if such technology offers marginally better patient outcomes. This is because new technology is almost always more expensive than “old technology,” and hospitals need resilience and reserve in their supply chain to be able to address pandemic-style demand shifts.
     
    3. Healthcare in general needs to adopt a different view on how technology is used. The environmental movement has created markets for recycling, repair services, and new products to embrace the idea that “things shouldn’t be used and thrown away.” The mantra of “reduce, reuse, recycle” has altered many industries, but healthcare, which is the second-largest generator of garbage in our economy, has not caught up. Instead, more and more devices are labeled “single-use,” and garbage truck after garbage truck hauls away medical and hospital waste from the hospital every day.

    Financial and Environmental Drivers in Healthcare
    During the Spring months of the pandemic where hospitals experienced a surge in critically ill patients, personal protective equipment (PPE) was in short supply, and hospitals, desperate to protect staff as well as patients, had to change the way they looked at face masks, gloves, shields, and gowns. Hospital staff was employed to sew face masks and asked to reuse them. Emergency Use Authorizations (EUAs) created a pathway for reprocessing and reusing PPE, at standards that were different and lower than normal standards for such practices. Essentially, a mindset change was demanded: “This is not garbage, this is an asset.”
     
    Reusing medical devices is not a new idea for hospitals that clean thousands of devices in their Sterile Processing Department (SPD) every day, but all of a sudden, the scope has changed, and broader reform of technology utilization is now on the agenda.
     
    The COVID-19 pandemic has created a confluence of the environmental and financial change drivers in healthcare. Reusing medical devices drives the cost savings necessary to stay resilient and prepared from a supply chain perspective, and it reduces costs to ensure that elective procedures drive profits for the hospital. It also ensures that fewer garbage trucks leave the hospital every day, and that environmental damage is reduced. In Europe and elsewhere, the term “circular economy” has become popular to represent this confluence of the values behind financial and environmental sustainability: If hospitals don’t throw away devices, but re-use them, they save the environment, and they reduce costs. “Circular economy” has indeed become a rallying cry behind efforts to redirect resource utilization in general and make it more sustainable.
     
    For manufacturers in healthcare, this represents a problem and an opportunity. American MedTech companies are driven by patient care demand to constantly launch new technologies (that are more expensive), to ensure these technologies drive the largest possible revenue, and to aggressively sell these new technologies to physicians and other healthcare professionals. American MedTech companies are not operating from a circular economy perspective, but there is an opportunity for companies to embrace the concept of the circular economy.
     
    They can do this by:
     
    • Focusing on sustainable technology development – combining financial sustainability with technology advancement (launching technologies that are both better and cheaper), so that technology is adopted faster by hospitals that operate under financial strain.
    • Developing reusable products – MedTech has been going in the opposite direction, increasingly launching “single-use” devices to drive revenue through new product sales; a return to reusable products could drive market share.
    • Leveraging reprocessing – combining existing or new technology solutions with the ability to “reprocess” the devices in controlled, safe facilities; this could drive market share and show a commitment to the financial sustainability of hospitals.
     
    In the specific case of catheter ablation, the circular economy mindset serves to address all three lessons learned from the pandemic. Single-use device reprocessing has been a common practice in most U.S. hospitals for decades, but recently, a surge in clearances for devices used in catheter ablations has shined a light on electrophysiology as an area of opportunity for cost savings. Single-use device reprocessing companies must go through an extensive, strict clearance process with FDA prior to being able to reprocess single-use devices and bring them back to the hospital for another use. This clearance process mirrors what other manufacturers have to go through, and clearance is only granted when data has demonstrated that reprocessed devices are functionally the same as new and do not present any added patient risk.
     
    Reprocessed devices are typically about half the price of new devices, and EP labs that embrace reprocessing can save almost 30 percent in device costs per catheter ablation procedure, equivalent to more than $3,000. This can change the equation for hospitals whose patient populations are largely CMS reimbursed and make catheter ablation a stronger profit contributor to hospitals struggling financially with the conditions of a pandemic. This also frees the extra resources hospitals need to juggle supply chain demands in the era of specific supply shortages.
     
    It would benefit manufacturers in the catheter ablation space to take a circular economy approach to their technology development and launches. This includes embracing reprocessing as a much-needed extension of the single-use lifetime of so many devices, so that hospitals can reduce waste and adopt new technologies with less impact on profitability. Based on current FDA clearances, fully leveraging single-use device reprocessing can save U.S. healthcare more than $700 million, reducing device spend from $2.5 billion to $1.8 billion.
     
    In addition to embracing single-use device reprocessing, the future will favor manufacturers that deliberately design technologies for re-use and balance the lure of new technology with the need for hospitals to remain financially stable.  
     

    Lars Thording, PhD, has a background in academia, consulting and industry leadership. He has been responsible for the launch of numerous market-disrupting solutions across healthcare, insurance and technology. Originally from Denmark, Thording has taught at universities in Denmark, Ireland and the United States. He currently serves as the vice president of marketing and public affairs at Innovative Health, a medical device reprocessing company specializing in electrophysiology and cardiology technology. Thording currently serves on the board of the Association of Medical Device Reprocessors.
    Related Searches
    • R&D & Design
    Related Knowledge Center
    • R&D & Design
    Suggested For You
    Heraeus Medevio Heraeus Medevio
    COVID Community: How the Pandemic Is Bringing Out the Best in Us COVID Community: How the Pandemic Is Bringing Out the Best in Us
    The FDA Wants to Bring Manufacturing ‘Home’ The FDA Wants to Bring Manufacturing ‘Home’
    Innovation and Expertise Drive Evolution in Medical Device Manufacturing Innovation and Expertise Drive Evolution in Medical Device Manufacturing
    Pandemic is Severely Impacting Reversible Contraceptive Devices Market Pandemic is Severely Impacting Reversible Contraceptive Devices Market
    Let There Be Light: UV Disinfection Technology Let There Be Light: UV Disinfection Technology
    AtriCure Promotes VP of Finance to CFO Position AtriCure Promotes VP of Finance to CFO Position
    Inventor of GORE-TEX Technology Dies at 83 Inventor of GORE-TEX Technology Dies at 83
    Varex Imaging Welcomes New Finance Chief Varex Imaging Welcomes New Finance Chief
    NextPhase Medical Device Announces New CCO NextPhase Medical Device Announces New CCO
    Survey: Virtual Care Will Likely Outlast the Pandemic Survey: Virtual Care Will Likely Outlast the Pandemic
    STEWART Industries Launches Medical Device Division STEWART Industries Launches Medical Device Division
    Freudenberg Buys Merit Medical Freudenberg Buys Merit Medical's Hypotube Manufacturing Biz
    4 Ways the IIoT Improves Medical Manufacturing 4 Ways the IIoT Improves Medical Manufacturing
    Managing Medtech Manufacturing Managing Medtech Manufacturing

    Related Buyers Guide Companies

    • Heraeus Medevio

      Heraeus Medevio

      Heraeus is a globally active precious metals and technology Group with firm roots in Germany, headquartered in Hanau near Frankfurt.
      Megan Erd, Global Marketing Coordinator 11.02.22

    • COVID Community: How the Pandemic Is Bringing Out the Best in Us

      COVID Community: How the Pandemic Is Bringing Out the Best in Us

      Given the brain power and generosity of our industry, I knew I could follow the wisdom of Fred Rogers’ mother and “look for the helpers.”
      Dawn A. Lissy, Founder & President, Empirical 10.01.20

    • Contract Manufacturing
      The FDA Wants to Bring Manufacturing ‘Home’

      The FDA Wants to Bring Manufacturing ‘Home’

      The agency commissioners comment how the need to modernize the critical medical supply chain is long overdue.
      Sean Fenske, Editor-in-Chief 10.01.20


    • Contract Manufacturing
      Innovation and Expertise Drive Evolution in Medical Device Manufacturing

      Innovation and Expertise Drive Evolution in Medical Device Manufacturing

      MICRO’s president offers a look at the company his family founded 75 years ago as well as the industry it’s supported.
      Brian Semcer, President, MICRO 09.29.20

    • Pandemic is Severely Impacting Reversible Contraceptive Devices Market

      Pandemic is Severely Impacting Reversible Contraceptive Devices Market

      U.S. revenue expected to be down 29 percent this year, experts predict.
      GlobalData 09.29.20

    Loading, Please Wait..

    Trending
    • Study: Catheter Ablation Significantly Lowers Dementia Risk In AFib Patients
    • Abbott's Proclaim XR SCS OK'ed For Diabetic Neuropathy
    • BMP Medical Expands Sterling, Massachusetts Facility
    • Tandem Diabetes Completes Deal For AMF Medical
    • The Future Of Biomedical Engineering Advancements
    Breaking News
    • BMP Medical Expands Sterling, Massachusetts Facility
    • Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    • Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    • Duane DiFranco Joins Harvard MedTech’s Medical Advisory Board
    • Lionel Bonte Named President of Mativ’s Healthcare and Wellness Business Unit
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients
    Vitamin D Supplementation Reduces Risk of Dynapenia
    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Coatings World

    Latest Breaking News From Coatings World

    Epoxytec Announces New Website Launch
    Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
    Axalta Releases Fourth Quarter and Full Year 2022 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BMP Medical Expands Sterling, Massachusetts Facility
    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pasithea Signs CMC Development and Manufacturing Agreement
    Experic Expands Analytical Capabilities and Facilities
    List Labs Expands Manufacturing Capacity
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
    TRESemmé Introduces New Pro Infusion Collection
    Walgreens Boots Alliance Shares 2022 ESG Report
    Happi

    Latest Breaking News From Happi

    KimChi Beauty Launches Spinning Hearts Love 02 Ahead of Valentine’s Day
    Dark & Lovely Names Actress Meagan Good Brand Ambassador
    Natural Household Care Company Tru Earth Adds Dishwasher Detergent Tablets
    Ink World

    Latest Breaking News From Ink World

    Xerox Releases 4Q, Full-Year 2022 Results
    Electronics For Imaging Names Frank Pennisi as CEO
    Fiery to Separate from EFI, Remain Wholly-Owned by Siris
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    EFI appoints Frank Pennisi CEO, Fiery now an independent business
    Bobst boosts senior sales team with Keith Nagle
    Penmar Industries adds Screen Truepress Jet L350UV SAI digital press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity’s Sales Grow
    Thinx to Pay up to $5 million to Settle Class Action Suit
    Typar Highlighting New Building Innovations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Launches the Mariner Deformity System
    Tyber Medical Hires 2 New Execs
    Miach Ortho Raises $40M in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Smart Devices with Privacy Focus Have More Consumer Appeal
    Siman Group Partners with SML to Unlock Full Retail Potential with RFID
    Brewer Science Presents Optics Integration Solutions at SPIE Photonics West

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login